Aldeyra Therapeutics, Inc. Annual Depreciation in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Aldeyra Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2014 to 2023.
  • Aldeyra Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $60.6K, a 9.47% decline year-over-year.
  • Aldeyra Therapeutics, Inc. annual Depreciation for 2023 was $263K, a 1.57% increase from 2022.
  • Aldeyra Therapeutics, Inc. annual Depreciation for 2022 was $259K, a 2.07% decline from 2021.
  • Aldeyra Therapeutics, Inc. annual Depreciation for 2021 was $264K, a 370% increase from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $263K +$4.07K +1.57% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 $259K -$5.47K -2.07% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 $264K +$208K +370% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 $56.2K -$40.1K -41.6% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-17
2019 $96.3K +$25.3K +35.6% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-11
2018 $71K +$33.2K +87.6% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
2017 $37.8K +$2.06K +5.75% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-08
2016 $35.8K +$17K +90.6% Jan 1, 2016 Dec 31, 2016 10-K 2017-03-30
2015 $18.8K +$17.7K +1657% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-30
2014 $1.07K Jan 1, 2014 Dec 31, 2014 10-K 2016-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.